| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3873789 | The Journal of Urology | 2007 | 6 Pages |
Abstract
We report that methylation of the 3 novel markers GPR7, ABHD9 and Chr3-EST is significantly associated with prostate cancer prognosis. Incorporation of these methylation markers into clinical practice will result in more accurate prediction of which patients are likely to experience PSA recurrence.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Susan Cottrell, Klaus Jung, Glen Kristiansen, Elke Eltze, Axel Semjonow, Michael Ittmann, Arndt Hartmann, Thomas Stamey, Carolina Haefliger, Gunter Weiss,